The market for PGD will continue to increase in the coming years as delays in conception among women, the occurrence of genetic diseases, and lifestyle changes which decrease women’s fertility continue to rise.

Transparency Market Research, “Preimplantation Genetic Diagnosis Market to Reach US$118.0 Million by 2020, Expected Due to PGD for Aneuploidy Screening,” Med Gadget, January 7, 2017.

URL: www.medgadget.com/2017/01/preimplantation-genetic-diagnosis-market-to-reach-us118-0-million-by-2020-expected-due-to-pgd-for-aneuploidy-screening.html